Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

Wockhardt

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Wockhardt's 2013 sales performance.

US generics face competition from India

Sun Pharma received 30 ANDA approvals in 2008, up from 20 in 2007, and Wockhardt was awarded 18 in 2008, against 13 the previous year.

Wockhardt aims for US takeover target

India-headquartered Wockhardt is in the final stages of acquiring US-based Morton Grove Pharmaceuticals. ... US sales currently contribute around nine per cent toward Wockhardt's revenue (approx.

NHS news in brief

Wockhardt UK, the government's second supplier of diamorphine after Chiron, has been contacted to provide extra supplies.

Pharma news in brief

Analysts said the deal would boost Dr Reddy's presence in Europe, which has up till now lagged behind Ranbaxy and another Indian rival, Wockhardt, to invest in Europe.

Meda builds marketing muscle

were reported to be interested as were Indian generics firms Ranbaxy Laboratories and Wockhardt.

[ Previous 5 results ] 1 2 3 [ Next 5 results ]

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
infill healthcare communication

infill is a dynamic and innovative, international healthcare agency with >25 years' experience in delivering healthcare communication, medical education and...

Latest intelligence

What challenges still face clinical trial recruitment and retention?
Discover the reasons for the current clinical trial recruitment challenges facing pharma and the life sciences industry, and how the search for solutions to the problem continues...
“Fake News” and Credibility in Medical Publishing
Natalie Yeadon from Impetus Digital shares her thoughts on fighting fake news in Pharma and healthcare....
Delivering true value: what does it mean for KAM in cancer care?
Lisa Alderson, Business Development Director at Wilmington Healthcare, explores the challenges that pharma’s KAM teams face in engaging with the NHS and how they must evolve...

Infographics